PatternsRadar
Sign in

DRREDDYDr. Reddy's Laboratories Limited

NSEF&O
Full chart
1,208.00INR+5.00 (+0.42%)Close · 6 Oct 2026
22 Jul 2026Last results
HealthcareSector
Pharmaceuticals & BiotechnologyIndustry
₹1.01L CrMarket cap
31.7P/E (TTM)
51.4%Delivery

Filings & corporate actions

82 results filed
CSV
Next results · Q2 FY27
Expected 24 Oct 2026 – 5 Nov 2026
Estimate: filed 24–36 days after quarter end, last 5 times
Dividend
₹8.00 per share · last 10 Jul 2026
2026
  • 22 JulresultsResults · Q1 FY27 · consolidated and standalone-1.4%NSE
  • 21 JulshareholdingShareholding · 30 Jun 2026-1.4%NSE
  • 10 JuldividendDividend · ₹8.00 per share-2.0%
  • 12 MayresultsResults · Q4 FY26 · consolidated and standalone-0.4%NSE
  • 21 AprshareholdingShareholding · 31 Mar 2026-1.0%NSE
  • 21 JanresultsResults · Q3 FY26 · consolidated and standalone+5.2%NSE
  • 20 JanshareholdingShareholding · 31 Dec 20250.0%NSE

Reaction to results · all yearsrose on day 0 in 37 of 78 CSV

QuarterFiledDay 0+5D+20DRel vol
Q1 FY2722 Jul 2026-1.4%-3.2%-0.2%2.4×
Q4 FY2612 May 2026-0.4%+4.1%+0.5%3.1×
Q3 FY2621 Jan 2026+5.2%+5.3%+10.8%4.7×
Q2 FY2624 Oct 2025+0.1%-6.8%-3.7%1.0×
Q1 FY2623 Jul 2025+1.5%+1.8%+2.4%2.8×
Q4 FY259 May 2025+3.4%+5.5%+14.1%2.3×
Q3 FY2524 Jan 2025-5.0%-5.6%-9.2%4.0×
Q2 FY255 Nov 2024+2.4%-2.1%-1.5%5.6×
Q1 FY2527 Jul 2024-0.6%-1.0%+1.2%1.5×
Q4 FY247 May 2024-3.2%-6.1%-6.9%2.5×
Q3 FY2430 Jan 2024+4.8%+5.8%+10.0%4.2×
Q2 FY2427 Oct 2023-1.0%-1.1%+5.2%1.4×
Q1 FY2426 Jul 2023+0.6%+3.4%+5.5%3.6×
Q4 FY2310 May 2023-6.9%-9.1%-4.5%8.5×
Q3 FY2325 Jan 2023+2.7%+3.7%+6.9%4.1×
Q2 FY2329 Oct 2022-0.6%+0.6%-0.2%5.2×
Q1 FY2328 Jul 2022-4.0%-2.4%-0.4%4.3×
Q4 FY2219 May 2022+8.1%+11.7%+5.5%6.6×
Q3 FY2228 Jan 2022-0.9%+2.2%-1.9%3.3×
Q2 FY2229 Oct 2021+3.1%+2.9%-1.1%1.4×
Q1 FY2227 Jul 2021-10.5%-12.7%-15.9%14.8×
Q4 FY2114 May 2021-2.0%-1.6%+2.9%2.0×
Q3 FY2129 Jan 2021-5.5%-1.5%-9.1%3.8×
Q2 FY2128 Oct 2020-0.2%+0.2%-2.5%1.0×
Q1 FY2129 Jul 2020+6.2%+13.6%+9.5%6.1×
Q4 FY2020 May 2020+5.7%+5.1%+8.3%3.4×
Q3 FY2027 Jan 2020+5.2%+3.7%+1.8%8.8×
Q2 FY201 Nov 2019-1.0%+1.4%+3.2%5.8×
Q1 FY2029 Jul 2019-3.5%-3.7%-4.8%4.2×
Q4 FY1917 May 2019-5.7%-3.2%-5.6%4.5×
Q3 FY196 Feb 2019+1.1%-4.4%-6.3%0.7×
Q2 FY1929 Oct 2018+2.4%-3.2%+4.8%1.2×
Q1 FY1913 Aug 2018+1.7%+9.9%+15.2%0.6×
Q4 FY1826 May 2018+1.4%+1.4%+16.4%1.0×
Q3 FY1830 Jan 2018-3.5%-8.4%-3.2%1.8×
Q2 FY181 Nov 2017-3.0%-3.4%-6.2%2.1×
Q1 FY181 Aug 2017-2.2%-15.8%-8.8%1.2×
Q4 FY173 Jun 2017-0.7%+3.0%+2.7%0.5×
Q3 FY176 Feb 2017-1.0%-5.0%-8.1%0.7×
Q2 FY1722 Dec 2016-0.8%+1.0%-3.2%1.1×
Q1 FY171 Oct 2016+1.7%-0.9%+4.9%1.0×
Q4 FY1616 May 2016+2.9%+3.9%+5.9%1.9×
Q3 FY1610 Feb 20160.0%+7.6%+11.3%1.7×
Q2 FY1629 Oct 2015+1.4%-14.0%-23.9%2.0×
Q1 FY1631 Jul 2015+1.7%+4.5%+5.6%1.0×
Q4 FY1521 May 2015+0.3%-2.2%-6.4%0.6×
Q3 FY1529 Jan 2015+3.8%-5.2%+1.2%4.2×
Q2 FY1529 Oct 2014+1.6%+13.0%+19.1%1.4×
Q1 FY151 Aug 2014-1.8%-0.9%+6.6%1.1×
Q4 FY1413 May 2014-4.1%-14.7%-12.0%2.8×
Q3 FY1411 Feb 2014-1.7%+0.3%+2.5%1.6×
Q2 FY146 Nov 2013-0.4%+2.6%+0.4%0.6×
Q1 FY1430 Jul 2013+4.8%+3.6%+5.3%1.6×
Q4 FY1327 May 2013+1.2%+3.2%+0.4%1.6×
Q3 FY1321 Feb 2013-0.2%-3.8%-2.9%0.5×
Q2 FY1330 Oct 2012+1.6%+5.2%+6.5%2.1×
Q1 FY1319 Jul 2012-1.1%-3.0%-0.2%2.9×
Q4 FY1211 May 2012-2.2%-2.2%-4.5%3.0×
Q3 FY123 Feb 2012+2.4%-0.6%+3.2%4.9×
Q2 FY1225 Oct 2011+2.3%+6.2%-0.3%3.3×
Q1 FY1220 Jul 2011-2.1%-0.6%-8.5%1.5×
Q4 FY1113 May 2011+3.3%+0.2%-2.3%3.6×
Q3 FY1125 Jan 2011-3.5%-1.4%-3.5%2.9×
Q2 FY1123 Oct 2010+1.8%+4.3%+9.4%0.8×
Q1 FY1122 Jul 2010-1.7%-1.9%-4.6%1.7×
Q4 FY106 May 2010+0.1%+2.5%+12.5%2.3×
Q3 FY1020 Jan 2010+1.8%-2.3%-5.4%2.7×
Q2 FY1023 Oct 2009+6.3%+12.0%+22.3%1.7×
Q1 FY1021 Jul 2009-5.1%+1.7%+1.0%3.0×
Q4 FY0918 May 2009-3.4%+7.9%+16.3%2.8×
Q3 FY0920 Jan 2009-4.5%-3.2%-13.2%1.6×
Q2 FY0923 Oct 2008-3.1%-10.5%-10.4%1.6×
Q1 FY0921 Jul 2008+2.3%-5.0%-9.1%3.4×
Q4 FY0820 May 2008+3.0%+6.7%+7.9%1.8×
Q3 FY0825 Jan 2008-6.3%-13.2%-10.5%1.6×
Q2 FY0824 Oct 2007-2.7%-2.4%-4.1%2.2×
Q1 FY0823 Jul 2007+0.6%-5.1%-6.9%1.7×
Q4 FY0718 May 2007-1.1%-1.6%-5.3%2.0×
Average-0.1%-0.3%+0.4%

Close-to-close from the session before the filing could trade. Day 0 is the first session after it.

Growth · Q1 FY27

CSV
Revenue YoY-5.5%
Profit YoY-69.1%
Interest cost YoY—
Revenue QoQ+7.3%
Profit QoQ+96.8%
CAGR2Y3Y4Y5Y6Y7Y
Revenue——————
Profit——————

Key data

CSV
Open1,207.00
Day range1,195.00 – 1,212.70
52-week range1,101.00 – 1,414.90
From 52w high-14.6%
RSI (14)54.2
ATR (14)24.47
Volume16.38L
Avg volume (20D)21.35L
Rel volume0.77×
Volatility (1Y)23.6%
Turnover₹197.9Cr
SMA 50 / 2001,178.11 / 1,246.42

Delivery percentage

Latest · 6 Oct 202651.4%
20-day avg56.2%
1-year avg55.2%
Percentile (own history)56th
Range3.7–83.1%
Sessions1,731

Over the last 20 sessions DRREDDY settled 56.2% of its traded quantity, which is above average for an NSE equity. That is in line with its own one-year average of 55.2%. The latest session ranks higher than 56% of the 1,731 sessions on record for it.

What delivery percentage measuresScan the whole market on delivery

IndustryPharmaceuticals
PeersDIVISLABLAURUSLABSSUNPHARMAWOCKPHARMAMOREPENLABZYDUSLIFE

Performance returns

CSV
1D1W1M3M6M1Y
Price+0.42%-1.06%+4.59%-10.82%-0.76%-3.60%

Valuation

CSV
Market cap₹1.01L Cr
P/E (TTM)31.7
EPS (TTM)38.14
Shares outstanding83.50Cr
Listed30 May 2003

Ownership

CSV
Promoter26.64%
Promoter Δ QoQ+0.01 pp
Public73.16%
FII32.07%
DII31.74%
Pledged0.00%

Quarterly results · consolidated

CSV
Q2 FY26Q3 FY26Q4 FY26Q1 FY27
Revenue (₹ Cr)8,828.38,753.47,546.48,099.8
YoY chg——-11.5%-5.5%
Net profit (₹ Cr)1,336.81,189.6221.3435.6
YoY chg——-86.1%-69.1%
Net margin15.1%13.6%2.9%5.4%
EPS16.1714.522.655.33

Shareholding over time

CSV

By quarter

30 Jun 2026 · promoter 26.64% · public 73.16%
30 Sept 2021: promoter 26.72%31 Dec 2021: promoter 26.72%31 Mar 2022: promoter 26.72%30 Jun 2022: promoter 26.71%30 Sept 2022: promoter 26.71%31 Dec 2022: promoter 26.70%31 Mar 2023: promoter 26.70%30 Jun 2023: promoter 26.69%30 Sept 2023: promoter 26.66%31 Dec 2023: promoter 26.65%31 Mar 2024: promoter 26.65%30 Jun 2024: promoter 26.65%30 Sept 2024: promoter 26.64%31 Dec 2024: promoter 26.64%31 Mar 2025: promoter 26.64%30 Jun 2025: promoter 26.64%30 Sept 2025: promoter 26.64%31 Dec 2025: promoter 26.64%31 Mar 2026: promoter 26.63%30 Jun 2026: promoter 26.64%
2021-092026-06
  • Promoter
  • Public and others
Promoter
26.64%
Public
73.16%
Promoter change
+0.01 pp
Filed
21 Jul 2026
FII
32.07%
DII
31.74%
Promoter pledged
0.00%

Promoter and public shares of total equity, from the pattern filed each quarter. Institutional and pledge figures come from a separate filing stage whose backfill is still running, so they are absent for almost every instrument rather than zero.

Financials · quarterly statement

CSV
₹ crore, as filed
 Q2 FY24Q3 FY24Q4 FY24AQ1 FY25Q2 FY25Q3 FY25Q4 FY25AQ1 FY26Q2 FY26Q3 FY26Q4 FY26AQ1 FY27
Revenue from operations6,902.67,236.87,113.87,696.18,038.28,381.28,528.48,572.18,828.38,753.47,546.48,099.8
Other income315.0216.2197.5187.2307.5150.2522.1290.3323.9268.8475.4354.7
Total income7,217.67,453.07,311.37,883.38,345.78,531.49,050.58,862.49,152.29,022.28,021.88,454.5
Total expenses5,305.15,626.65,709.66,006.66,434.46,661.37,050.86,957.67,413.77,481.37,826.77,902.0
└ Finance costs35.339.459.359.875.781.765.683.090.794.4105.7125.5
└ Depreciation375.5373.5367.7380.6397.0471.4454.7476.1504.6521.0557.1536.6
Profit before tax1,912.51,826.41,601.71,876.71,911.31,870.11,999.71,904.81,738.51,540.9195.1552.5
Tax expense434.5448.2295.4490.2575.5470.1418.5495.1408.0353.6(21.6)117.7
Net profit1,482.21,380.91,309.81,392.41,341.91,404.21,586.71,409.91,336.81,189.6221.3435.6
EPS17.8216.5915.7316.723.0216.9719.1217.0416.1814.532.655.33
Net margin21.47%19.08%18.41%18.09%16.69%16.75%18.60%16.45%15.14%13.59%2.93%5.38%
PBT margin27.71%25.24%22.52%24.39%23.78%22.31%23.45%22.22%19.69%17.60%2.59%6.82%
Tax rate22.72%24.54%18.44%26.12%30.11%25.14%20.93%25.99%23.47%22.95%-11.07%21.30%

A audited · R restated by a later filing · negatives in parentheses. EPS and the share count are restated onto the same split-adjusted basis as the price chart, so they can be read against it; every rupee figure is exactly as filed. A quarterly filing carries a profit and loss only — there is no balance sheet behind it, and so no debt, cash flow or return-on-capital figure here. Latest filed 22 Jul 2026.

DRREDDY at a glance

  • DRREDDY closed at ₹1,208 on 6 Oct 2026, +0.42% on the day, -3.6% over one year, 14.6% below its 52-week high of ₹1,414.9.
  • Delivery was 51.4% of traded quantity on 6 Oct 2026, the 56th percentile of its own 1,731 sessions with a reading (20-session average 56.2%, 1-year average 55.2%).
  • Market capitalisation is ₹1.01 lakh crore at a trailing P/E of 31.7 (trailing EPS ₹38.14).
  • Q1 FY27 results (consolidated, filed 22 Jul 2026): revenue ₹8,100 crore (-5.5% year on year), net profit ₹436 crore (-69.1%); the price moved -1.4% on the first session after.
  • Promoters held 26.64% at 30 Jun 2026, up 0.01 percentage points on the previous filing.
  • Q2 FY27 results are expected between 24 Oct 2026 and 5 Nov 2026, going by past filing dates — an estimate, not an announcement.

About

CSV
Macro sectorHealthcare
Basic industryPharmaceuticals
ISININE089A01031
SeriesEQ
Listed30 May 2003
History from2 Jan 1995
Sessions7,853
Turnover rank#107

Prices are adjusted for splits and bonuses. Delivery figures come from NSE’s daily reports and are unavailable for older sessions. Sourced from the eod2 dataset, last updated 6 Oct 2026.

More in Pharmaceuticals & Biotechnology

CSV

All Pharmaceuticals & Biotechnology stocks on the NSEAll Healthcare stocks on the NSE